Jeffrey E. Russel

Array ( [id] => 1373104 [patent_doc_number] => 06562787 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Hybrid polypeptides with enhanced pharmacokinetic properties' [patent_app_type] => B1 [patent_app_number] => 09/834784 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 26 [patent_no_of_words] => 18365 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562787.pdf [firstpage_image] =>[orig_patent_app_number] => 09834784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1370810 [patent_doc_number] => 06558702 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-06 [patent_title] => 'Method of modifying the release profile of sustained release compositions' [patent_app_type] => B2 [patent_app_number] => 09/835001 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9409 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/558/06558702.pdf [firstpage_image] =>[orig_patent_app_number] => 09835001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342835 [patent_doc_number] => 06582713 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-24 [patent_title] => 'Compositions and methods for promoting wound healing' [patent_app_type] => B2 [patent_app_number] => 09/823851 [patent_app_country] => US [patent_app_date] => 2001-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9022 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/582/06582713.pdf [firstpage_image] =>[orig_patent_app_number] => 09823851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196303 [patent_doc_number] => 07635751 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-22 [patent_title] => 'Peptides having ligand activities on APJ that is an orphan G protein-coupled receptor, and use thereof' [patent_app_type] => utility [patent_app_number] => 10/239321 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17832 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 267 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/635/07635751.pdf [firstpage_image] =>[orig_patent_app_number] => 10239321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1116394 [patent_doc_number] => 06800728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-10-05 [patent_title] => 'Hydrazine-based and carbonyl-based bifunctional crosslinking reagents' [patent_app_type] => B2 [patent_app_number] => 09/815978 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15689 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/800/06800728.pdf [firstpage_image] =>[orig_patent_app_number] => 09815978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7403212 [patent_doc_number] => 20040023857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Treatment of rosacea' [patent_app_type] => new [patent_app_number] => 10/221933 [patent_app_country] => US [patent_app_date] => 2002-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3651 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023857.pdf [firstpage_image] =>[orig_patent_app_number] => 10221933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016874 [patent_doc_number] => 20020103133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use' [patent_app_type] => new [patent_app_number] => 09/808832 [patent_app_country] => US [patent_app_date] => 2001-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25861 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103133.pdf [firstpage_image] =>[orig_patent_app_number] => 09808832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1156238 [patent_doc_number] => 06764993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-20 [patent_title] => 'Use of o-vanillin and o-vanillin/trolox combinations' [patent_app_type] => B2 [patent_app_number] => 09/805016 [patent_app_country] => US [patent_app_date] => 2001-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2854 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/764/06764993.pdf [firstpage_image] =>[orig_patent_app_number] => 09805016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1059598 [patent_doc_number] => 06852688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-08 [patent_title] => 'Compositions for treating diabetic retinopathy and methods of using same' [patent_app_type] => utility [patent_app_number] => 09/804484 [patent_app_country] => US [patent_app_date] => 2001-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6662 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/852/06852688.pdf [firstpage_image] =>[orig_patent_app_number] => 09804484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6874847 [patent_doc_number] => 20030195144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'Antimicrobial compounds and formulations' [patent_app_type] => new [patent_app_number] => 10/221040 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21222 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20030195144.pdf [firstpage_image] =>[orig_patent_app_number] => 10221040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6361048 [patent_doc_number] => 20020058611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Carrier for in vivo delivery of a therapeutic agent' [patent_app_type] => new [patent_app_number] => 09/802109 [patent_app_country] => US [patent_app_date] => 2001-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18482 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058611.pdf [firstpage_image] =>[orig_patent_app_number] => 09802109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1398339 [patent_doc_number] => 06531449 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-11 [patent_title] => 'Hexahydropyrazolo4,3,-cpyridine metabolites' [patent_app_type] => B2 [patent_app_number] => 09/801964 [patent_app_country] => US [patent_app_date] => 2001-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13071 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531449.pdf [firstpage_image] =>[orig_patent_app_number] => 09801964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1150252 [patent_doc_number] => 06770627 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-03 [patent_title] => 'Piperizine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p 53' [patent_app_type] => B1 [patent_app_number] => 09/786702 [patent_app_country] => US [patent_app_date] => 2001-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14279 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770627.pdf [firstpage_image] =>[orig_patent_app_number] => 09786702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668279 [patent_doc_number] => 20030113262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Gpib-lipid bond construct and use thereof' [patent_app_type] => new [patent_app_number] => 10/220610 [patent_app_country] => US [patent_app_date] => 2002-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6019 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113262.pdf [firstpage_image] =>[orig_patent_app_number] => 10220610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1297905 [patent_doc_number] => 06627604 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-30 [patent_title] => 'Memno peptides, process for their preparation and use thereof' [patent_app_type] => B2 [patent_app_number] => 09/794346 [patent_app_country] => US [patent_app_date] => 2001-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8154 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/627/06627604.pdf [firstpage_image] =>[orig_patent_app_number] => 09794346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745638 [patent_doc_number] => 20030022821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Bioactive peptides' [patent_app_type] => new [patent_app_number] => 09/798869 [patent_app_country] => US [patent_app_date] => 2001-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25382 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022821.pdf [firstpage_image] =>[orig_patent_app_number] => 09798869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1252493 [patent_doc_number] => 06669951 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-30 [patent_title] => 'Compositions and methods for enhancing drug delivery across and into epithelial tissues' [patent_app_type] => B2 [patent_app_number] => 09/792480 [patent_app_country] => US [patent_app_date] => 2001-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 51 [patent_no_of_words] => 37688 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/669/06669951.pdf [firstpage_image] =>[orig_patent_app_number] => 09792480 [rel_patent_id] =>[rel_patent_doc_number] =>)